Jun-ichi Oshida
Tokyo Institute of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jun-ichi Oshida.
Tetrahedron Letters | 1979
Yoshiro Kobayashi; Takeo Taguchi; Tadafumi Terada; Jun-ichi Oshida; Masuo Morisaki; Nobuo Ikekawa
Abstract From cholenic acid 24,24-difluoro-25-hydroxyvitamin D 3 and 24ξ-fluoro-25-hydroxyvitamin D 3 were prepared.
Tetrahedron Letters | 1980
Jun-ichi Oshida; Masuo Morisaki; Nobuo Ikekawa
Abstract 2β-Fluoro-1α-hydroxyvitamin D 3 ( 3 ) was prepared from 1,2α-epoxy-cholest-5-en-3β-yl tetrahydropyranyl ether( 1a via 2β-fluorocholest-5-ene-1α, 3β-diol( 2 ).
Journal of The Chemical Society-perkin Transactions 1 | 1982
Yoshiro Kobayashi; Takeo Taguchi; Tadafumi Terada; Jun-ichi Oshida; Masuo Morisaki; Nobuo Ikekawa
To clarify the physiological significance of C-24 hydroxylation in vitamin D3 metabolism, vitamin D3 compounds blocked at C-24 by fluorine substituents, namely 24,24-difluoro-25-hydroxyvitamin D3(1) and 24ξ-fluoro-25-hydroxyvitamin D3(2) have been synthesized from 3β-hydroxychol-5-en-24-oic acid (13).
Tetrahedron Letters | 1981
Yoshiro Kobayashi; Takeo Taguchi; Norio Kanuma; Nobuo Ikekawa; Jun-ichi Oshida
Two new fluorinated 25-hydroxyvitamin D3 analogs, 26,26,26-trifluoro- 25-hydroxy (1) and 27-nor-26,26,26-trifluoro-25-hydroxyvitamin D3 (2), were prepared from 24-phenylsulfonyl 25,26,27-triorcholest-5-en-3β-yl tetrahydropyranyl ether (3).
Archives of Biochemistry and Biophysics | 1990
Tamio Koizumi; Yoshinobu Nakao; Seiichi Ishizuka; Jun-ichi Oshida; Noriyuki Hara; Nobuo Ikekawa; Takuo Fijita
Novel vitamin D3 derivatives, 26-homo-delta 22-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-1 alpha,25(R)-dihydroxyvitamin D3 were compared with the native hormone, 1,25-dihydroxyvitamin D3, and with other vitamin D3 derivatives, in inhibition of cell growth, induction of phenotypic differentiation, and c-myc mRNA reduction of HL-60 cells. The degree of inhibition in cell growth caused by 26-homo-delta 22-1 alpha,25(S)-(OH)2D3 was the greatest followed by 26-homo-delta 22-1 alpha,25(R)-(OH)2D3. The ability to reduce NBT was parallel to that to inhibit cellular proliferation. 26-homo-delta 22-1 alpha,25(S)-(OH)2D3, 26-homo-delta 22-1 alpha,25(R)-(OH)2D3, 24-homo-24-F2-1 alpha,25-(OH)2D3, and 1 alpha,24(R)-(OH)2-26-Cl-D3 were more active than 1 alpha,25-(OH)2D3 in the induction of OK-M1+ and OK-Mo-2+ HL-60 cells. Using two color flow cytometric analysis, the percentages of OK-M5(+)- and OK-DR(+)-HL-60 cells were 33% in the treatment with 26-homo-delta 22-1 alpha,25(S)-(OH)2D3 plus interferon-gamma (IFN-gamma) but 14% in the treatment with 1 alpha,25-(OH)2D3 plus IFN-gamma. 26-Homo-delta 22-1 alpha,25(S)-(OH)2D3 has an inhibitory effect on c-myc reduction in treated HL-60 cells. These results suggest that the novel vitamin D3 derivatives, 26-homo-delta 22-1 alpha,25(S)-(OH)2D3 and 26-homo-delta 22-1 alpha,25(R)-(OH)2D3, have preferential activity in inducing phenotypic differentiation and in inducing cell proliferation related c-myc mRNA activity.
Journal of The Chemical Society, Chemical Communications | 1980
Yoshiro Kobayashi; Takeo Taguchi; Norio Kanuma; Nobuo Ikekawa; Jun-ichi Oshida
In order to investigate the biological significance of 26-hydroxylation of vitamin D3, 26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3 was prepared from 24-tosyloxy-25,26,27-trinorcholest-5-en-3β-yl tetrahydropyranyl ether.
Tetrahedron-asymmetry | 1999
Jun-ichi Oshida; Makoto Okamoto; Shizuo Azuma
Abstract 1α,24( R )-Dihydroxycholesterol, which is the key intermediate for the synthesis of 1α,24( R )-dihydroxyvitamin D 3 , was effectively synthesized via stereoselective esterification of the 24( R )-hydroxy group using a lipase in combination with inversion of configuration of the 24( S )-hydroxy group using the Mitsunobu reaction ( R : S =99:1).
Bioorganic & Medicinal Chemistry Letters | 1999
Jun-ichi Oshida; Makoto Okamoto; Seiichi Ishizuka; Shizuo Azuma
Abstract 1 α ,24( R )-Dihydroxy-25-nitrovitamin D 3 1 and 1 α ,24( S )-dihydroxy-25-nitrovitamin D 3 2 were synthesized using the palladium-catalyzed alkylative enyne cyclization reaction. Their biological properties were studied based on VDR binding affinity and HL-60 cell differentiation activity.
Chemical & Pharmaceutical Bulletin | 1980
Nobuo Ikekawa; Yutaka Hirano; Masaji Ishiguro; Jun-ichi Oshida; Tadashi Eguchi; Satoru Miyasaka
Archive | 1999
Shizuo Azuma; Masato Okamoto; Jun-ichi Oshida; 真人 岡本; 淳一 押田; 静男 東
Collaboration
Dive into the Jun-ichi Oshida's collaboration.
Niigata University of Pharmacy and Applied Life Sciences
View shared research outputs